Myriad Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Myriad Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-113,059	Closed	-$12.2M	–	116
2020 Q1	$12.2M	Buy	113,059 +46,040	+69%	+$5.29M	1.82%	16
2019 Q4	$7.8M	Buy	67,019 +34,362	+105%	+$3.98M	0.94%	28
2019 Q3	$3.74M	Buy	+32,657	New	+$3.25M	0.38%	45
2019 Q2	–	Sell	-52,349	Closed	-$4.78M	–	124
2019 Q1	$4.78M	Sell	52,349 -33,087	-39%	-$2.71M	0.43%	51
2018 Q4	$6.49M	Buy	85,436 +70,936	+489%	+$5.22M	1.38%	22
2018 Q3	$1.16M	Buy	14,500 +11,000	+314%	+$1.02M	0.17%	58
2018 Q2	$348K	Buy	+3,500	New	+$302K	0.05%	60
2017 Q3	–	Sell	-101,900	Closed	-$11.5M	–	90
2017 Q2	$11.5M	Hold	101,900	–	–	0.8%	29
2017 Q1	$10.2M	Buy	+101,900	New	+$10.9M	0.76%	36
2016 Q4	–	Sell	-133,913	Closed	-$16.7M	–	61
2016 Q3	$16.7M	Buy	+133,913	New	+$15.8M	1.06%	27
2015 Q3	–	Sell	-35,000	Closed	-$4.03M	–	51
2015 Q2	$4.03M	Buy	+35,000	New	+$3.68M	0.46%	40

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Myriad Asset Management's CBPO Position: Q2 2020 in Review

Myriad Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2020, closing a stake of 113,059 shares — an estimated $12.2M sold.

Myriad Asset Management first reported a position in CBPO in Q2 2015 and held it in 11 quarters. The position peaked at $16.7M in Q3 2016. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2020.

Myriad Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
Myriad Asset Management sold 113,059 China Biologic Products Holdings, Inc. shares in Q2 2020, an estimated $12.2M.
Myriad Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 11 quarters.
Myriad Asset Management's China Biologic Products Holdings, Inc. position peaked at $16.7M in Q3 2016.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2020.

Based on Myriad Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.